Effects of Age, Drug Dose, and Sampling Time on Salivary Levels of Olanzapine, Quetiapine, and Their Metabolites
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Age, Drug Dose, and Sampling Time on Salivary Levels of Olanzapine, Quetiapine, and Their Metabolites
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 10, Pages 3288
Publisher
MDPI AG
Online
2020-10-17
DOI
10.3390/jcm9103288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Retrospective Analysis of Steady-state Olanzapine Concentrations in Chinese Patients using Therapeutic Drug Monitoring
- (2020) Shu-hua Deng et al. THERAPEUTIC DRUG MONITORING
- Diagnostic Value of Salivary Markers in Neuropsychiatric Disorders
- (2019) Agnieszka Kułak-Bejda et al. DISEASE MARKERS
- Simultaneous Quantification of Antipsychotic and Antiepileptic Drugs and Their Metabolites in Human Saliva Using UHPLC-DAD
- (2019) Dziurkowska et al. MOLECULES
- Potential of Oral Fluid as a Clinical Specimen for Compliance Monitoring of Psychopharmacotherapy
- (2018) Jasna Neumann et al. THERAPEUTIC DRUG MONITORING
- Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients
- (2018) Katharina Ebert et al. THERAPEUTIC DRUG MONITORING
- Salivary biomarkers for the diagnosis and monitoring of neurological diseases
- (2018) Raymond Farah et al. Biomedical Journal
- Solid Phase Extraction Purification of Saliva Samples for Antipsychotic Drug Quantitation
- (2018) Ewelina Dziurkowska et al. MOLECULES
- A compilation of serum concentrations of 12 antipsychotic drugs in a therapeutic drug monitoring setting
- (2018) Anna K. Jönsson et al. THERAPEUTIC DRUG MONITORING
- Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders
- (2017) Laura Albantakis et al. PHARMACOPSYCHIATRY
- Therapeutic drug monitoring of atypical antipsychotics.
- (2017) Anna Urban et al. Psychiatria Polska
- Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other Factors
- (2012) Danielle S. Fisher et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetic Variability of Quetiapine and the Active Metabolite N-desalkylquetiapine in Psychiatric Patients
- (2011) Gry Vibeke Bakken et al. THERAPEUTIC DRUG MONITORING
- Large Intraindividual Variability of Olanzapine Serum Concentrations in Adolescent Patients
- (2009) Christian J Bachmann et al. THERAPEUTIC DRUG MONITORING
- The Relationship Between the Response of Clinical Symptoms and Plasma Olanzapine Concentration, Based on Pharmacogenetics
- (2009) Motohiro Nozawa et al. THERAPEUTIC DRUG MONITORING
- Sex, Race, and Smoking Impact Olanzapine Exposure
- (2008) Kristin L. Bigos et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More